Scope Biosciences is a on-site development platform technology specializing in the development of molecular diagnostics using CRISPR-Cas.
Scope Biosciences has raised €1.5M across 3 funding rounds from 4 investors, most recently a round in Jun 2025. Based in Wageningen, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-06-16 | Other | — | Oost NL,SHIFT Invest | View deal → |
| 2023-10-25 | Other | €500k | OostNL,SHIFT Invest | View deal → |
| 2021-11-16 | Other | €1.0M | GenDx | View deal → |
